Schroder Investment Management Group
OLMA icon

Schroder Investment Management Group’s Olema Pharmaceuticals OLMA Stock Holding History

Schroder Investment Management Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-618,184
Closed -$2.63M – 1241
2025
Q2 		$2.63M Buy
618,184
+85,073
+16% +$379K ﹤0.01% 874
2025
Q1 		$2.19M Hold
533,111
– – ﹤0.01% 897
2024
Q4 		$2.99M Buy
533,111
+450,924
+549% +$4.5M ﹤0.01% 867
2024
Q3 		$1M Sell
82,187
-77,552
-49% -$991K ﹤0.01% 1028
2024
Q2 		$1.73M Buy
+159,739
New +$1.73M ﹤0.01% 949

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Schroder Investment Management Group's OLMA Position: Q3 2025 in Review

Schroder Investment Management Group sold out of Olema Pharmaceuticals (OLMA) in Q3 2025, closing a stake of 618,184 shares — an estimated $2.63M sold.

Schroder Investment Management Group first reported a position in OLMA in Q2 2024 and held it in 5 quarters. The position peaked at $2.99M in Q4 2024. 126 funds tracked by Wall St. Rank hold OLMA as of Q3 2025.

  • Schroder Investment Management Group reported no remaining Olema Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 618,184 Olema Pharmaceuticals shares in Q3 2025, an estimated $2.63M.
  • Schroder Investment Management Group first reported a position in Olema Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Schroder Investment Management Group's Olema Pharmaceuticals position peaked at $2.99M in Q4 2024.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.